119 filings
Page 3 of 6
8-K
mti2 fgrk0n5ixivm
7 Jan 21
Sage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conference
4:14pm
8-K
l37g9rg3
31 Dec 20
Other Events
4:05pm
8-K
cy8oc5w f1
16 Dec 20
Departure of Directors or Certain Officers
7:00am
8-K
a9hagkq9q3it ckrwgo
27 Nov 20
Entry into a Material Definitive Agreement
7:38am
8-K
xd7h09pd2m0yjqwd
5 Nov 20
Sage Therapeutics Announces Third Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
8-K
eaprpshn7o9 m457go5
15 Oct 20
Sage Therapeutics Announces Positive Interim, Topline Zuranolone
9:14am
8-K
9z4o8e3s
1 Oct 20
Sage Therapeutics Appoints Barry Greene to Board of Directors
4:05pm
8-K
etdz1nj38d
10 Aug 20
Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
8-K
7unbomce sy
10 Jun 20
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
wcksh0l9r4eflv
7 May 20
Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
4:27pm
8-K
8iygqot16s24
7 Apr 20
Sage Therapeutics Announces Restructuring to Advance Corporate Strategy and Pipeline
4:25pm
8-K
vssni arf
18 Mar 20
Sage Therapeutics Announces Development Plan for Zuranolone(SAGE-217) Following
6:57am
8-K
7uocfx jigdx5rw0de
27 Feb 20
Sage Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
b2b1w
5 Dec 19
Sage Therapeutics Reports Topline Results from Pivotal Phase 3
7:01am
8-K
1mygybdmbj 0193
12 Nov 19
Sage Therapeutics Announces Third Quarter 2019 Financial Results and Highlights
6:44am
8-K
67kso
6 Aug 19
Results of Operations and Financial Condition
7:04am
8-K
mt2 r9hzaq6dzzb4j78
24 Jul 19
Sage Therapeutics Announces Clinical Updates and Progress Across Neuroscience Pipeline
7:18am
8-K
vv2s3dbyi
14 Jun 19
Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSOâ„¢ (brexanolone) Injection
9:03am
8-K
ri3facerdt42676dpx
6 Jun 19
Submission of Matters to a Vote of Security Holders
4:36pm
8-K
199 oci6tg98klga4
2 May 19
Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
7:25am